ZR2 Bioenergy Limited posts ₹22.01 lakh Q1 profit without revenue

ZR2 Bioenergy Limited posted a standalone net profit of ₹22.01 lakh for the quarter ended June 30, 2026, despite reporting nil revenue from operations; total income was ₹41.63 lakh and consisted entirely of other income, down 10.3% year-on-year.

How did ZR2 Bioenergy perform in Q1 FY27?

ZR2 Bioenergy reported a standalone net profit of ₹22.01 lakh in Q1 FY27, compared with ₹17.06 lakh in the corresponding quarter of FY26, representing a 29% year-on-year increase. The company disclosed the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026 after its Board meeting on August 14, 2026.

The quarterly result shows that the reported profit was earned without operating revenue. Revenue from operations was recorded as nil for June 2026, March 2026 and June 2025 in the standalone quarterly statement. Total income of ₹41.63 lakh was therefore fully accounted for by other income.

Other income declined from ₹46.43 lakh in Q1 FY26 to ₹41.63 lakh in Q1 FY27. Although total income was lower than a year earlier, the standalone net profit increased from ₹17.06 lakh. The supplied result summary also places the latest quarter's profit below ₹19.89 lakh reported in Q4 FY26.

What do the quarterly financial figures show?

The quarterly figures show that ZR2 Bioenergy's Q1 FY27 earnings remained dependent on non-operating income rather than revenue generated through its stated operations. The company reported total income of ₹41.63 lakh in the quarter, compared with ₹43.81 lakh in the quarter ended March 31, 2026 and ₹46.43 lakh in the quarter ended June 30, 2025.

The company reported consolidated net profit of ₹22.01 lakh for Q1 FY27. The result summary compares this with consolidated net profit of ₹30.54 lakh in Q1 FY26 and ₹19.89 lakh in Q4 FY26. The available quarterly statement lists consolidated other income at ₹41.63 lakh and consolidated total income at the same amount.

What is the background to ZR2 Bioenergy's recent results?

ZR2 Bioenergy's latest disclosure follows audited results for the quarter and year ended March 31, 2026, which the Board considered on May 29, 2026. For FY26, the standalone statement supplied with the June-quarter filing reported total income of ₹183.82 lakh, while the consolidated statement reported total income of ₹186.82 lakh.

For FY25, the company reported total revenue of ₹149.45 lakh, compared with ₹157.37 lakh in FY24. These figures were presented in the company's 86th annual report for the year ended March 31, 2025. The annual-report comparison indicates that total revenue declined by ₹7.92 lakh from the preceding financial year.

The supplied data also identifies the company as formerly Gujchem Distillers India Ltd. It records three corporate events and a latest dividend of ₹0.10 per share dated September 10, 2025. No further details on the business operations underlying the nil quarterly operating revenue were provided in the supplied material.

Why does nil operating revenue matter to investors?

Nil operating revenue matters because the Q1 FY27 profit was supported entirely by other income of ₹41.63 lakh. This makes the composition of income an important point when assessing the quarter, as no revenue was reported from operations in the latest quarter or in the two comparative periods displayed in the financial statement.

The reported profit increase should therefore be read alongside the decline in total income. Standalone total income fell by ₹4.80 lakh, or 10.3%, from ₹46.43 lakh in Q1 FY26, even as standalone net profit rose by ₹4.95 lakh. The supplied disclosures do not provide a share-price movement or trading-volume response to the result.

For shareholders, the result also creates a distinction between profitability in the reported period and the company's ability to generate operating revenue. The available information confirms the accounting outcomes for the quarter but does not state a timeline or plan for restoring revenue from operations.

What should investors track in ZR2 Bioenergy's next disclosures?

Investors should track whether ZR2 Bioenergy reports revenue from operations in subsequent quarterly results and whether other income continues to account for all reported income. Comparing total income, net profit and the source of earnings across quarters will be relevant because Q1 FY27 total income declined year-on-year while net profit increased.

Investors may also monitor Board disclosures issued under Regulations 30 and 33 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015. These filings are the company's stated channel for financial-result outcomes and related information.

Conclusion

ZR2 Bioenergy reported a ₹22.01 lakh standalone Q1 FY27 net profit despite having no revenue from operations. Total income was ₹41.63 lakh, entirely from other income, and was lower than the ₹46.43 lakh reported in the year-earlier quarter. The result highlights that the company's quarterly profitability did not arise from operating revenue.

The next point to watch is the company's subsequent quarterly disclosure for evidence of operating revenue and details on the composition of other income. The supplied filing does not disclose a target or timetable for operating recovery, making future Board-approved results the key scheduled source of further information.